AR018532A1 - Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas - Google Patents

Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas

Info

Publication number
AR018532A1
AR018532A1 ARP980106554A ARP980106554A AR018532A1 AR 018532 A1 AR018532 A1 AR 018532A1 AR P980106554 A ARP980106554 A AR P980106554A AR P980106554 A ARP980106554 A AR P980106554A AR 018532 A1 AR018532 A1 AR 018532A1
Authority
AR
Argentina
Prior art keywords
proteins
beta
blt
lipoprotein
substantially pure
Prior art date
Application number
ARP980106554A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR018532A1 publication Critical patent/AR018532A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Se trata de proteínas sustancialmente puras que contienen análogos de la beta-lipoproteína (BLT); aislados de ácidos nucleicos que codifican dichasproteínas y formulaciones farmacéuticas que comprenden las proteínas. También se proporcionan composiciones farmacéuticas que comprenden beta-lipotropina yutiles para el tratamiento de la diabetes y complicaciones asociadas con la misma mediante la administracion de una cantidad eficaz de beta-lipotropina. Dichasproteínas comprenden a las secuencias de aminoácidos.
ARP980106554A 1997-12-23 1998-12-21 Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas AR018532A1 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6865997P 1997-12-23 1997-12-23
US7985798P 1998-03-30 1998-03-30
US8632198P 1998-05-21 1998-05-21
US9138598P 1998-07-01 1998-07-01
US9540598P 1998-08-05 1998-08-05
US10397698P 1998-10-13 1998-10-13

Publications (1)

Publication Number Publication Date
AR018532A1 true AR018532A1 (es) 2001-11-28

Family

ID=27557000

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106554A AR018532A1 (es) 1997-12-23 1998-12-21 Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas

Country Status (18)

Country Link
US (2) US6323178B1 (es)
EP (1) EP0926239A3 (es)
JP (1) JP2001526061A (es)
KR (1) KR20010024805A (es)
CN (1) CN1284882A (es)
AR (1) AR018532A1 (es)
AU (1) AU1938599A (es)
BR (1) BR9814433A (es)
CA (1) CA2315888A1 (es)
CO (1) CO4930304A1 (es)
EA (1) EA200000709A1 (es)
HR (1) HRP20000426A2 (es)
HU (1) HUP0100132A2 (es)
IL (1) IL136514A0 (es)
PE (1) PE20000062A1 (es)
PL (1) PL341293A1 (es)
TR (1) TR200002611T2 (es)
WO (1) WO1999032142A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1409535A2 (en) * 2000-12-13 2004-04-21 Incyte Genomics, Inc. Human secreted proteins
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8227194B2 (en) * 2005-04-08 2012-07-24 University Of Maryland, Baltimore Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
EP2276405A4 (en) * 2008-05-12 2013-10-09 Us Dept Veterans Affairs AUTOMATED SYSTEM AND METHOD FOR DIABETES CONTROL

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
CA2170641C (en) * 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5691309A (en) 1995-01-31 1997-11-25 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
KR20010024805A (ko) 2001-03-26
WO1999032142A1 (en) 1999-07-01
HRP20000426A2 (en) 2000-10-31
IL136514A0 (en) 2001-06-14
TR200002611T2 (tr) 2000-12-21
EP0926239A2 (en) 1999-06-30
CO4930304A1 (es) 2000-06-27
EA200000709A1 (ru) 2000-12-25
HUP0100132A2 (hu) 2001-05-28
US20030073621A1 (en) 2003-04-17
EP0926239A3 (en) 2002-08-28
PE20000062A1 (es) 2000-02-08
CA2315888A1 (en) 1999-07-01
BR9814433A (pt) 2000-10-10
CN1284882A (zh) 2001-02-21
JP2001526061A (ja) 2001-12-18
AU1938599A (en) 1999-07-12
US6323178B1 (en) 2001-11-27
PL341293A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
ES2153362T3 (es) Composiciones y procedimientos de administracion sublingual o bucal de agentes terapeuticos.
IL90423A (en) Interleukin-1 inhibitors methods for producing them pharmaceutical compositions containing them isolated DNA sequences encoding interleukin-1 inhibitors and host cells and vectors containing them
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
ES2150983T3 (es) Productos proteicos bactericidas estables que incrementan la permeabilidad y composiciones farmaceuticas que los contienen.
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
ES2166166T3 (es) Analogos de peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen.
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
DE69525544D1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DE69804865T2 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
BR0312889A (pt) Polipeptìdeo t20 peguilado
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
AU2043388A (en) Cyclic peptides as promoters of absorption on administration onto the mucosa
NO931400L (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
DE69227979D1 (de) Modifizierte VIP-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
MY104088A (en) Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.
AR011535A1 (es) Composicion de enjuagues bucales que comprende clorhexidina y polivinilpirrolidona
AR004497A1 (es) Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica.
DK0612763T3 (da) Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
DE3586752D1 (de) Verfahren zur herstellung wundheilungsfoerdernder praeparationen und solche praeparationen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal